Advisors Preferred’s Ligand Pharmaceuticals LGND Stock Holding History

Advisors Preferred's LGND Position: Q3 2015 in Review

Advisors Preferred sold out of Ligand Pharmaceuticals (LGND) in Q3 2015, closing a stake of 603 shares — an estimated $38K sold.

Advisors Preferred first reported a position in LGND in Q4 2013 and held it in 3 quarters. The position peaked at $38K in Q2 2015. 203 funds tracked by Wall St. Rank hold LGND as of Q3 2015.

• Advisors Preferred reported no remaining Ligand Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
• Advisors Preferred sold 603 Ligand Pharmaceuticals shares in Q3 2015, an estimated $38K.
• Advisors Preferred first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 3 quarters.
• Advisors Preferred's Ligand Pharmaceuticals position peaked at $38K in Q2 2015.
• 203 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2015.

Based on Advisors Preferred's 13F filing for Q3 2015, filed 2 Nov 2015.